Development and characterization of a rat model of nonpenetrating liver trauma

Comparative Medicine

Volumn 60, Issue 3, 2010, Pages 218-224

  Cox, Jennifer M ^a   Kalns, John E ^a  

^a Hyperion Biotechnology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; CYTOKINE; NOS2 PROTEIN, RAT; SOCS3 PROTEIN, RAT; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLUNT TRAUMA; CONTROLLED STUDY; KUPFFER CELL; LIVER HEMORRHAGE; LIVER INJURY; LIVER NECROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; THROMBOCYTE COUNT; ANIMAL; BLEEDING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INJURY; LIVER; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION; HEMORRHAGE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; MALE; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; WOUNDS AND INJURIES;

EID: 77954208247     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anthony MT, Zeigler ZR, Lister J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN, Silver B, Joyce R, Bodensteiner D. 1998. Plasminogen activator inhibitor (PAI1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. Am J Hematol 59:9-14. (Pubitemid 28395000)
2. Bakker FC, Wille F, Patka P, Haarman HJ. 1995. Surgical treatment of liver injury with an absorbable mesh: an experimental study. J Trauma 38:891-894.
3. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. 2006. Critical role of plasminogen activator inhibitor 1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 316:592-600. (Pubitemid 43130985)
4. Binder BR, Christ G, Gruber F, Grubic N, Hufnagl P, Krebs M, Mihaly J, Prager GW. 2002. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17:56-61.
5. Bozova S, Elpek GO. 2007. Hypoxia-indudble factor 1α expression in experimental cirrhosis: correlation with vascular endothelial growth fartor expression and angiogenesis. Acta Pathol Microbiol Emmunol Scand 115:795-801. (Pubitemid 47030103)
6. Brooks AJ, Price V, Simms M. 2005. FAST on operational military deployment. Emerg Med J 22:263-265.
7. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, Heinrich PC, Fausto N. 2001. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 107:1285-1292. (Pubitemid 32494545)
8. Chen T, Zamora R, Zuckerbraun B, Billiar TR. 2003. Role of nitric oxide in liver injury. Curr Mol Med 3:519-526. (Pubitemid 37168596)
9. Eitzman DT, Fay WP, Lawrence DA, Francis-Chmura AM, Shore JD, Olson ST, Ginsburg D. 1995. Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor 1 in vitro. J Clin Invest 95:2416-2420.
10. Holbrook TL, Hoyt DB, Eastman AB, Sise MJ, Kennedy F, Velky T, Conroy C, Pacyna S, Erwin S. 2007. The impact of safety belt use on liver injuries in motor vehicle crashes: the importance of motor vehicle safety systems. J Trauma 63:300-306. (Pubitemid 47254638)
11. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
12. Kogure K, Ishizaki M, Nemoto M, Kuwano H, Makuuchi M. 1999. A comparative study of the anatomy of rat and human livers. J Hepatobitiary Pancreat Surg 6:171-175.
13. Kolios G, Valatas V, Kouroumalis E. 2006. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 12:7413-7420.
14. Kuboki S, Schuster R, Blanchard J, Pritts TA, Wong HR, Lentsch AB. 2006. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice. Am J Physiol Gastrointest Liver Physiol 292:G1141-G1149. (Pubitemid 46557791)
15. Moore EE, Cogbil TH, Jurkovitch GJ, Shackford SR, Malangoni MA, Champion HR. 1995. Organ injury scaling - spleen, liver (1994 rev). J Trauma 38:323-324.
16. Renckens R, Roelofs JJ, de Waard V, Florquin S, Lijnen HR, Carmeliet P, van der Poll T. 2005. The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. J Thromb Haemost 3:1018-1025.
17. Stefanovic L, Brenner DA, Stefanovic B. 2005. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med (Maywood) 230:573-586. (Pubitemid 41233157)
18. Stracieri LD, Scarpelini S. 2006. Hepatic injury. Acta Cir Bras 21 Suppl 1:85-88.
19. Tang J, Wang Y, Mei X, An L, Li J, Lin Q. 2007. The value of contrast-enhanced gray-scale ultrasound in the diagnosis of hepatic trauma: an animal experiment. J Trauma 62:1468-1472.
20. Valentino M, Serra C, Pavlica P, Labate AM, Lima M, Baroncini S, Barozzi L. 2008. Blunt abdominal trauma: diagnostic performance of contrast-enhanced US in children-initial experience. Radiology 246:903-909.
21. Wahl M, Gadzijev EM, Wahl J, Ravnik D, Pecar J, Pleskovic A. 2005. An experimental model of reprodudble liver trauma. Injury 36:963-969. (Pubitemid 40968163)
22. Yoon W, Jeong YY, KLm JK, Seo JJ, Lim HS, Shin SS, Kim JC, Jeong SW, Park JG, Kang HK. 2005. CT in blunt Uver trauma. Radiographics 25:87-104.